器官移植受者黑素瘤特征:澳大利亚移植皮肤科专科门诊10年队列研究
该回顾性研究纳入澳大利亚一家移植皮肤科专科门诊10年间监测的327例器官移植受者,共随访1280患者年,诊断11例新发原发性黑素瘤,平均距首次移植5.5年,仅2例Breslow厚度>1 mm,7例(64%)为新发,4例存在相邻痣,随访期间无转移且全部存活,每诊断1例黑素瘤需切除16个色素性病变。
要点
- 器官移植受者黑素瘤多在专科监测中早期发现,仅少数厚度>1 mm。
- 多数黑素瘤为新发,部分与相邻痣相关,随访期间无转移。
- 每诊断1例黑素瘤需切除16个色素性病变,在高危人群中可接受。
核心结论
- 在专科移植皮肤科门诊监测的器官移植受者中,大多数黑素瘤被早期诊断,早期检测可能减少厚黑素瘤的比例并改善预后。
研究设计与样本
- 回顾性研究,纳入澳大利亚一家专科移植皮肤科门诊10年间监测的327例器官移植受者,总随访1280患者年。
主要发现
- 共诊断11例新发原发性黑素瘤,平均距首次移植至诊断间隔5.5年。
- 仅2例黑素瘤Breslow厚度>1 mm。
- 7例(64%)黑素瘤为新发,4例存在相邻痣。
- 随访期间黑素瘤患者未发生转移,全部存活。
关键数值与推荐
- 每诊断1例黑素瘤需切除的色素性病变数为16:1。
临床怎么用
- 对器官移植受者进行专科皮肤监测有助于早期发现黑素瘤,每诊断1例黑素瘤切除16个色素性病变的比值在高危人群中可接受。
局限性
- 粗发病率经年龄标准化,与一般人群黑素瘤比较率不同;队列样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited information on the profile of melanomas diagnosed in a specialist transplant dermatology clinic. OBJECTIVE: To describe the incidence and characteristics of incident primary melanomas in a cohort of organ transplant recipients (OTRs) attending a specialized transplant dermatology clinic and determine the number of pigmented lesions needed to excise for every melanoma diagnosed. METHODS: A retrospective study of 327 OTRs monitored by an Australian clinic during a 10-year period. RESULTS: There were 11 incident melanomas diagnosed during a total follow-up of 1280 patient-years. The mean interval between the first transplant and diagnosis was 5.5 years. Only 2 melanomas were >1 mm in Breslow thickness. Seven melanomas (64%) arose de novo. A contiguous nevus was present in 4 cases. Metastatic disease did not develop in the melanoma patients during the follow-up period, and all remain alive. The needed to excise for every melanoma diagnosed ratio was 16:1. LIMITATIONS: The crude incidence rates were age standardized, unlike the comparison rates of melanoma in the general population, and the cohort was small. CONCLUSION: Most melanomas diagnosed in OTR patients attending a specialized transplant dermatology service were detected early. Our data suggest early detection may reduce the proportion of OTRs presenting with thick melanomas, thus improving prognosis and patient outcomes. A needed to excise for every melanoma diagnosed ratio of 16:1 is not unreasonable for this cohort of high-risk patients. To our knowledge, this is the first time this ratio has been calculated for a cohort of OTRs.
引用
- Maor D, Vajdic CM, Cumming S, et al. Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia. J Am Acad Dermatol. 2019. PMID: 31706934. doi:10.1016/j.jaad.2019.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。